Skip to content

Clinical trials

Recruiting Urinary Bladder Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Status: Recruiting Country / region: China Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20191
20201
20214
20222
20235
202416
202518
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting60

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University7
Zhujiang Hospital5
Qilu Hospital of Shandong University4
Tianjin Medical University Second Hospital4
Eli Lilly and Company3
Peking University First Hospital3
RenJi Hospital3
Cancer Institute and Hospital, Chinese Academy of Medical Sciences2
Changhai Hospital2
Daiichi Sankyo2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms60
Carcinoma, Transitional Cell11
Prostatic Neoplasms7
Esophageal Neoplasms6
Non-Muscle Invasive Bladder Neoplasms5
Ovarian Neoplasms5
Pancreatic Neoplasms5
Neoplasm Metastasis4
Stomach Neoplasms4
Uterine Cervical Neoplasms4

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.